Abstract
Three patients with hemiballismus received intravenous flumazenil and placebo in a double-blind cross-over study aimed to investigate whether an antagonistic action at the level of the GABA-benzodiazepine receptors may improve choreoballistic movements. No clinical benefit was seen.
Original language | English |
---|---|
Pages (from-to) | 470-472 |
Journal | Clinical Neuropharmacology |
Volume | 17 |
Issue number | 5 |
DOIs | |
Publication status | Published - 1 Jan 1994 |
Keywords
- Flumazenil
- GABA
- GABA-benzodiazepine receptors
- Hemiballismus